Active GLP-1 use after an overdose was associated with a 39% lower risk of a repeat overdose between 30 days and three years after the overdose event, compared to patients who were never prescribed a GLP-1, as seen in Figure 1
Clinical Context for GLP-1 Medications in 2026 This is not about Found Health specifically - this is about understanding the medications themselves so you can have an informed conversation with your provider about what might be appropriate for you
Refrigerate after reconstitution according to laboratory protocols
Fortunately, with personalized support from Castlight Healths GLP-1 & Weight Management Program, organizations can balance both cost containment and members receiving curated care based on clinical appropriateness
2026 Pureform Peptides (Pureform Labs)
Generic or undated COAs, or those from in-house labs only, are insufficient verification